AngioDynamics | ANGO - Operating Profit


AngioDynamics reported $-9.97M in Operating Profit for its fiscal quarter ending in February of 2025.





Operating Profit Change Date
AngioDynamics USD -9.97M 1.12M Feb/2025
AtriCure USD 208K 4.03M Sep/2025
Boston Scientific USD 1.24B 203M Dec/2025
Edwards Lifesciences USD 370.3M 54.8M Dec/2025
ICU Medical USD 26.86M 52K Sep/2025
Inogen USD -7.79M 728K Sep/2024
J&J USD 5.59B 1.81B Dec/2025
Medtronic USD 1.7B 100M Sep/2025
Merit Medical Systems USD 42.61M 4.41M Sep/2025
Mesa Laboratories USD 5.78M 2.27M Dec/2024
Orthofix International USD -84.62M 65.72M Dec/2024
Smiths GBP 242M 21M Dec/2025
Surmodics USD -5.64M 276K Sep/2024
Tandem Diabetes Care USD -22.86M 9M Sep/2025
Teleflex USD -408.9M 586.38M Sep/2025
Terumo JPY 45.1B 10.79B Sep/2025
Trinity Biotech USD -509K 6.27M Sep/2025